CAMBRIDGE, Mass., July 31, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference callon Tuesday, August 7, 2018, at 4:30 p.m. ET to review its second quarter 2018 financial results and provide an update on the company.
A live webcast of the conference call can be accessed
About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact: Daniella Funaro, Stern Investor Relations, Inc.212-362-1200 or firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-second-quarter-2018-financial-results-conference-call-and-webcast-300689428.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!